QUCHIP · Project

Photonic Chips That Run Quantum Simulations Faster Than Any Classical Computer

digitalPrototypeTRL 3Thin data (2/5)

Imagine you need to simulate how a new drug molecule behaves, but even your most powerful computer would take months to crunch the numbers. QUCHIP built tiny chips that use particles of light — photons — to run these simulations in ways classical computers simply cannot. Think of it like replacing a calculator with a purpose-built machine that solves one type of problem impossibly fast. The team created working chip prototypes with built-in photon sources, light-routing circuits, and detectors, all on a single integrated platform.

By the numbers

consortium partners

countries in consortium (AT, BE, DE, IT, UK)

total project deliverables

demonstrated prototype deliverables

industry participation ratio

The business problem

What needed solving

Companies in pharma, materials science, and advanced manufacturing face simulation problems that push classical computers to their limits — modeling molecular interactions, optimizing complex networks, or predicting material behavior can take weeks or prove outright impossible. These computational bottlenecks slow down R&D cycles and delay time-to-market for new products.

The solution

What was built

The project built integrated photonic chip prototypes for quantum simulation, including: reconfigurable 3D waveguide structures fabricated by femtosecond laser writing with thermal phase shifters, polarization-entangled photon sources on lithium niobate wafers with integrated polarizing beam splitters, and waveguide arrays demonstrating noise-assisted quantum transport. A total of 24 deliverables were produced across the 3-year project.

Audience

Who needs this

Quantum computing hardware startups seeking photonic chip architecturesPharmaceutical companies with large-scale molecular simulation needsPhotonics component manufacturers looking for next-generation product linesMaterials science R&D departments hitting classical computation limitsNational quantum technology programs seeking proven chip-scale platforms

Business applications

Who can put this to work

Pharmaceutical & Drug Discovery

enterprise

Target: Mid-to-large pharma companies with computational chemistry departments

If you are a pharmaceutical company spending weeks simulating molecular interactions for drug candidates — this project developed integrated photonic chips capable of quantum simulation that could dramatically accelerate how you model complex molecular dynamics. The 3D reconfigurable waveguide structures with thermal phase shifters allow tuning simulations to match specific molecular problems. With 9 partners across 5 countries contributing to 24 deliverables, the underlying science is well-validated at lab scale.

Photonics & Semiconductor Manufacturing

mid-size

Target: Photonic component manufacturers and foundries

If you are a photonics manufacturer looking for next-generation product lines — this project proved that complex quantum circuits can be fabricated using femtosecond laser writing on glass substrates with integrated thermal shifters. The polarization-entangled photon sources built on lithium niobate wafers represent a new class of components your fabrication lines could produce. These are building blocks for an emerging quantum photonics market.

Materials Science & Advanced Simulation

enterprise

Target: Companies with R&D departments running large-scale simulations

If you are a materials company whose R&D team hits computational walls when simulating new material properties — this project demonstrated noise-assisted quantum transport in waveguide arrays that mirrors how energy moves through complex networks. The reconfigurable three-arm interferometer devices allow testing different simulation configurations on the same chip. This could eventually replace months of classical computation for specific material behavior models.

Frequently asked

Quick answers

What would this technology cost to implement?

Based on available project data, no pricing or cost information is provided. The technology is still at a research stage, built within an entirely academic consortium of 9 partners. Commercial pricing would depend on future photonic chip fabrication scaling and packaging, which is not yet established.

Can this work at industrial scale?

Not yet. The project demonstrated lab-scale prototypes including reconfigurable 3D integrated waveguide structures and on-chip entangled photon sources. However, with 0 industrial partners and 0% industry participation in the consortium, scaling to commercial production was not part of the project scope. The project does note that integrated quantum photonics can capitalize on existing multi-billion dollar photonics manufacturing infrastructure.

What is the IP and licensing situation?

The project was coordinated by Universita degli Studi di Roma La Sapienza with 8 university partners and 1 research organization across 5 countries. IP would be distributed among these academic institutions under the EU grant agreement terms. Licensing discussions would need to go through the individual partner technology transfer offices.

How close is this to a product I can buy?

This is pre-commercial research. The 3 demonstrated deliverables — a reconfigurable 3D integrated structure, noise-assisted transport in waveguide arrays, and a polarization-entangled photon source — are laboratory demonstrations. The project aimed to reach 'quantum supremacy' regime where quantum devices outperform classical ones, but commercial products are still years away.

Can this integrate with our existing computing infrastructure?

Based on available project data, integration with classical computing systems was not a focus. The photonic chips operate as standalone quantum simulation devices. Future hybrid quantum-classical architectures would be needed for enterprise integration, but this was outside the project scope.

What regulations apply to quantum computing technology?

Based on available project data, regulatory aspects were not addressed. Quantum technologies are increasingly subject to export controls in the EU and internationally. Any commercialization path would need to account for dual-use technology regulations, particularly given the consortium spans 5 countries including the UK post-Brexit.

Consortium

Who built it

This is a purely academic consortium — 8 universities and 1 research organization across 5 European countries (Austria, Belgium, Germany, Italy, UK), with zero industrial partners and zero SMEs. The 0% industry ratio means the project had no built-in path to commercialization. For a business considering this technology, that means any commercial development would start from scratch: you would need to license from academic tech transfer offices and invest in engineering the lab prototypes into manufacturable products. The upside is that the research base is strong — 9 institutions contributed 24 deliverables over 3 years, and the coordinator (Sapienza University of Rome) is a leading European physics institution.

UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZACoordinator · IT
UNIVERSITAT WIENparticipant · AT
UNIVERSITAET ULMparticipant · DE
UNIVERSITE LIBRE DE BRUXELLESparticipant · BE
CONSIGLIO NAZIONALE DELLE RICERCHEparticipant · IT
UNIVERSITY OF SOUTHAMPTONparticipant · UK
UNIVERSITY OF BRISTOLparticipant · UK
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORDparticipant · UK
UNIVERSITAET PADERBORNparticipant · DE

How to reach the team

Coordinator is at Universita degli Studi di Roma La Sapienza (Italy). Contact their physics department or technology transfer office for licensing inquiries.

Order a report on this consortium See UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA profile →

Next steps

Talk to the team behind this work.

Want to explore how quantum photonic simulation could fit your R&D roadmap? SciTransfer can connect you with the QUCHIP research team and help assess commercial viability for your specific use case.

Order a report on this topic More in Digital & ICT